15 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
medicines. Backed by an expert team and a strong balance sheet, we stand well positioned to advance our gene editing therapies and fundamentally change
S-1
EX-10.11
s57l74spyrsjn
28 May 21
IPO registration
4:04pm
S-1
EX-10.9
bpxl7
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
diugmmdxt3wqaoov
28 May 21
IPO registration
4:04pm
S-1
EX-10.12
j78ez4wi4nu9t
28 May 21
IPO registration
4:04pm
S-1
EX-10.17
8ke6wjhpgnsfofmw
28 May 21
IPO registration
4:04pm
DRS
EX-10.13
osd45i
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
nahscp
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
pi0xp0
16 Apr 21
Draft registration statement
12:00am
DRS
dge5xk x5611kd
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
9a0q6odj
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next